Retension Pharmaceuticals Inc. (RTSN) Stock Ticker
RTSN right now
Market factors today
Unlock the full RTSN picture
About Retension Pharmaceuticals Inc.
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension. The company was founded by Eric Keller and Paul Sweetnam in 2023 and is headquartered in Falls Church, VA.
RTSN stock facts
| Ticker symbol | RTSN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $49.1M |
| CEO | Eric L. Keller |
| Employees | 12 |
| Headquarters | Falls Church, VA, US |
| IPO date | 2026-10-09 |
| Website | www.retensionpharmaceuticals.com |
What you can see for RTSN on Tickr
Live RTSN price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the RTSN report.
Rankings
FAQ
What is the ticker symbol for Retension Pharmaceuticals Inc.?
The ticker symbol for Retension Pharmaceuticals Inc. is RTSN, listed on the NASDAQ.
What is RTSN?
Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the…